Overview

Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical

Status:
Unknown status

Trial end date:
2018-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether Endostar pumping into vein with Thalidomide are more effective in the treatment of Advanced Colorectal Cancer (ACRC).

Phase:

Phase 3

Details

Lead Sponsor:

The First People's Hospital of Hefei

Collaborators:

Anhui Cancer Hospital
Anhui Jimin Cancer Hospital
Anhui Provincial Cancer Hospital
Simcere Pharmaceutical Co., Ltd

Treatments:

Endostar protein
Endostatins
Thalidomide